心脏MRI评估STEMI后心肌损伤的组织学验证综述
该综述总结了心脏MRI在ST段抬高型心肌梗死(STEMI)后评估心肌损伤的组织学验证证据。T2加权成像和T2* mapping分别显示水肿和心肌内出血,晚期钆增强(LGE)可确定急性梗死面积并最准确地显示微血管阻塞(MVO),后者以出血、微血管损伤和坏死为组织学特征。慢性期LGE用于检测替代性纤维化(最终梗死面积)。native T1 mapping是无对比剂测量梗死面积的新方法,但仍劣于LGE。
要点
- LGE心脏MRI是显示MVO最准确的方法,MVO组织学特征为出血、微血管损伤和坏死。
- T2加权成像不宜用于界定风险区域,因T2值在STEMI后数天内动态变化且受治疗影响。
- 慢性期LGE用于检测替代性纤维化(最终梗死面积),native T1 mapping劣于LGE。
关键影像表现/征象
- STEMI后不久,T2加权成像显示水肿,T2* mapping显示心肌内出血(IMH)。
- 急性梗死面积可通过LGE心脏MRI确定。
- LGE心脏MRI是显示MVO最准确的方法,MVO组织学特征为出血、微血管损伤和坏死。
- 慢性期LGE心脏MRI用于检测替代性纤维化,即损伤愈合后的最终梗死面积。
- native T1 mapping是无对比剂测量梗死面积的方法,但劣于LGE心脏MRI。
诊断标准与关键数值
- LGE心脏MRI定义的梗死面积及MVO的存在和范围可用于监测再灌注损伤和治疗干预的效果。
- T2加权MRI不应用于界定风险区域,因T2值在STEMI后数天内动态变化且T2异常严重程度可受治疗调节。
临床应用与阅片要点
- 急性期联合T2加权成像和T2* mapping分别评估水肿和心肌内出血。
- 使用LGE评估急性梗死面积和MVO,慢性期评估替代性纤维化(最终梗死面积)。
- 避免用T2加权成像界定风险区域,因其动态变化且受治疗影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cardiac MRI is a noninvasive diagnostic tool using nonionizing radiation that is widely used in patients with ST-segment elevation myocardial infarction (STEMI). Cardiac MRI depicts different prognosticating components of myocardial damage such as edema, intramyocardial hemorrhage (IMH), microvascular obstruction (MVO), and fibrosis. But how do cardiac MRI findings correlate to histologic findings? Shortly after STEMI, T2-weighted imaging and T2* mapping cardiac MRI depict, respectively, edema and IMH. The acute infarct size can be determined with late gadolinium enhancement (LGE) cardiac MRI. T2-weighted MRI should not be used for area-at-risk delineation because T2 values change dynamically over the first few days after STEMI and the severity of T2 abnormalities can be modulated with treatment. Furthermore, LGE cardiac MRI is the most accurate method to visualize MVO, which is characterized by hemorrhage, microvascular injury, and necrosis in histologic samples. In the chronic setting post-STEMI, LGE cardiac MRI is best used to detect replacement fibrosis (ie, final infarct size after injury healing). Finally, native T1 mapping has recently emerged as a contrast material-free method to measure infarct size that, however, remains inferior to LGE cardiac MRI. Especially LGE cardiac MRI-defined infarct size and the presence and extent of MVO may be used to monitor the effect of new therapeutic interventions in the treatment of reperfusion injury and infarct size reduction. © RSNA, 2021 Online supplemental material is available for this article.
引用
- Beijnink CWH, van der Hoeven NW, Konijnenberg LSF, et al. Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction: A Review of Its Histologic Validation. Radiology. 2021. PMID: 34427461. doi:10.1148/radiol.2021204265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。